Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol

Guardado en:
Detalles Bibliográficos
Autores principales: Jean-Pierre Van Geertruyden, Pierre Van Damme, Ynke Larivière, Vivi Maketa, Junior Matangila, Patrick Mitashi, Jessie De Bie, Trésor Zola, Elke Stoppie, Hypolite Muhindo-Mavoko
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Medicine
R
Acceso en línea:https://doaj.org/article/6ab5033e4ccb40efbb012094069c25e3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6ab5033e4ccb40efbb012094069c25e3
record_format dspace
spelling oai:doaj.org-article:6ab5033e4ccb40efbb012094069c25e32021-11-18T19:30:04ZOpen-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol10.1136/bmjopen-2020-0468352044-6055https://doaj.org/article/6ab5033e4ccb40efbb012094069c25e32021-09-01T00:00:00Zhttps://bmjopen.bmj.com/content/11/9/e046835.fullhttps://doaj.org/toc/2044-6055Jean-Pierre Van GeertruydenPierre Van DammeYnke LarivièreVivi MaketaJunior MatangilaPatrick MitashiJessie De BieTrésor ZolaElke StoppieHypolite Muhindo-MavokoBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 11, Iss 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Jean-Pierre Van Geertruyden
Pierre Van Damme
Ynke Larivière
Vivi Maketa
Junior Matangila
Patrick Mitashi
Jessie De Bie
Trésor Zola
Elke Stoppie
Hypolite Muhindo-Mavoko
Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
format article
author Jean-Pierre Van Geertruyden
Pierre Van Damme
Ynke Larivière
Vivi Maketa
Junior Matangila
Patrick Mitashi
Jessie De Bie
Trésor Zola
Elke Stoppie
Hypolite Muhindo-Mavoko
author_facet Jean-Pierre Van Geertruyden
Pierre Van Damme
Ynke Larivière
Vivi Maketa
Junior Matangila
Patrick Mitashi
Jessie De Bie
Trésor Zola
Elke Stoppie
Hypolite Muhindo-Mavoko
author_sort Jean-Pierre Van Geertruyden
title Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
title_short Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
title_full Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
title_fullStr Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
title_full_unstemmed Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
title_sort open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against ebola in the democratic republic of the congo: the study protocol
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/6ab5033e4ccb40efbb012094069c25e3
work_keys_str_mv AT jeanpierrevangeertruyden openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
AT pierrevandamme openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
AT ynkelariviere openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
AT vivimaketa openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
AT juniormatangila openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
AT patrickmitashi openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
AT jessiedebie openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
AT tresorzola openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
AT elkestoppie openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
AT hypolitemuhindomavoko openlabelrandomisedclinicaltrialtoevaluatetheimmunogenicityandsafetyofaprophylacticvaccinationofhealthcareprovidersbyadministrationofaheterologousvaccineregimenagainstebolainthedemocraticrepublicofthecongothestudyprotocol
_version_ 1718420732328804352

Ejemplares similares